Requests that the FDA amend the labeling information for Toradol (oral) (ketorolac tromethamine tablets) to indicate that Toradol (oral) (ketorolac tromethamine tablets) is approved for use only in conjunction with a primary mode of therapy (postsurgical opioid analgesia or opioid analgesia if the FDA wishes to keep the indication for general acute pain). | Federal Regulations · Congress.wiki